Utilization of lectin-histochemistry in forensic neuropathology: Lectin staining provides useful information for postmortem diagnosis in forensic neuropathology

Legal Medicine

Volumn 5, Issue 3, 2003, Pages 117-131

  Nishi, Katsuji ^a   Tanegashima, Akio ^a   Yamamoto, Yoshio ^a   Ushiyama, Ikuko ^a   Ikemoto, Keiko ^a   Yamasaki, Shigeru ^a   Nishimura, Akiyoshi ^b   Rand, Steven ^c   Brinkmann, Bernd ^c  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Carbohydrate deposits; Forensic neuropathology; Human brain; Lectin stain

Indexed keywords

CARBOHYDRATE; CONCANAVALIN A; GLYCOCONJUGATE; LECTIN;

ALZHEIMER DISEASE; AUTOPSY; BLOOD VESSEL; BRAIN DEGENERATION; BRAIN DISEASE; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN MITOCHONDRION; BRAIN TISSUE; CAUSE OF DEATH; COGNITIVE DEFECT; DENTATE GYRUS; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FORENSIC PATHOLOGY; HIPPOCAMPUS; HISTOCHEMISTRY; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEURORADIOLOGY; REVIEW; SCHIZOPHRENIA; SENILITY; STAINING; WHITE MATTER;

EID: 0242636913     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1344-6223(03)00058-0     Document Type: Review

References (97)

1. Edelman GM. Cell adhesion molecules. Science 1983;219:450-7.
2. Oohira A. Functional roles of neurocan in neural network formation and injury of the brain. Cell Technol (In Japanese) 2001;20:1101-6.
3. Aalendoerfer KL, Magbani JL, Patterson PH. FORSE-1, an antibody that labels regionally restricted subpopulations of progenitor cells in the embryonic central nervous system, recognizes the Le(x) carbohydrate on a proteoglycan and two glycolipid antigens. Mol Cell Neurosci 1995;56:381-95.
4. Mai JK, Schoenlau CH. Age-related expression patterns of the CD15 epitope in the human lateral geniculate nucleus (LGN). Histochem J 1995;24:878-89.
5. Mann DMA, Bonshek RE, Marcyniuk B, Stoddart RW, TorgersonE. Saccharides of senile plaques and neurofibrillary tangles in Alzheimer's disease. Neurosci Lett 1989;85:277-82.
6. Nishimura A, Ikemoto K, Satoh K, Yamamoto Y, Rand S, Brinkmann B, Nishi K. The carbohydrate deposits detected by histochemical methods in the molecular layer of the dentate gyrus in the hippocampal formation of patients with schizophrenia, Down's syndrome and dementia, and aged person. Glycoconjugate J 2000;17:815-22.
7. Wiederschain GYa Koul O, Aucoin JM, Smith FI, McCluer RH. Alpha-1, 3 fucosyltransferase, alpha-L-fucosidase, alpha-D-galactosidase, beta-D-galactosidase, and Le x glycoconjugate in developing rat brain. Glycoconjugate J 1998;15:379-88.
8. Luebke T, Marquardt T, Etzioni A, Hartmann E, Figura K, Koerner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorder of glycosylation, as a GDP-fucose transport deficiency. Nat Genet 2001;28:73-6.
9. Spicer SS, Schulte BA. Abundance and diversity of glycoconjugate visualized cytochemically in the nervous system. Acta Histochem Cytochem 1995;28:85-91.
10. Ito N, Nishi K, Nakajima M, Ishitani A, Okamura Y, Hirota T. Histochemical reactivity of soybean agglutinin with blood group antigens and their precursor substances in acinar cells of human pancreas. J Histochem Cytochem 1987;35:881-90.
11. Nishimura A, Sawada S, Ushiyama I, Yamamoto Y, Nakagawa T, Tanegashima A, Nishi K. Lectin-histochemical detection of degenerative glycoconjugate deposits in human brain. Forensic Sci Int 2000;113:265-9.
12. Nishimura A, Sawada S, Ushiyama I, Tanegashima A, Nakagawa T, Ikemoto K, Yamamoto Y, Satoh K, Rand S, Brinkmann B, Nishi K. Postmortem diagnosis of brain disorders. The histochemical detection of glycoconjugate deposition with lectins. Internet J Forensic Med Toxicol 2000; 1. http://anil299.tripod.com/vol-001-no-002/paper003.hyml.
13. Nishimura A, Ushiyama I, Yamamoto Y, Yamada M, Ohts M, Nagatomo M, Nishi K. Histochemical characterization of lectin binding in human brain. Proceedings of the 6th Indo Pacific Congress on Legal Medicine and Forensic Science 1999;564-7.
14. Braak H, Braak E. Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 1987;756:124-7.
15. Foster NL, Wihelmsen K, Sima AAF. Fronttemporal dementia and Parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol 1993;41:706-15.
16. Hirano A, Malamud N, Kurlando LT. Parkinsonism-dementia complex; An endemic disease on the Island of Guam: Pathological feature. Brain 1961;84:662-79.
17. Kosaka K. Diffuse Lewy body disease. Neuropathology 2000;20:S73-8.
18. Kosaka K, Iseki E. Recent advances in dementia research in Japan: Non-Alzheimer-type degenerative dementias. Psychiatr Clin Neurosci 1998;52:367-73.
19. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. Subtypes and differential laminar distributions of beta/A4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases. Acta Neuropathol 1991;81:328-335.
20. Spargo E, Luthert PJ, Janoto I, Lantons PL. Beta/A4 deposition in the temporal cortex of adults with Down syndrome. J Neurosci 1992;111:26-32.
21. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Master CL, Grzeschik K-H, Multhaup G, Beyreuther K, Mueller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:736-44.
22. Weidemann A, Koenig G, Bunke D, Fischer P, Salbaum JM, Master CL, Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989;57:115-26.
23. Sawada S, Nishimura A, Ushiyama I, Nakagawa T, Yamamoto Y, Nishi K. The triple staining method with the silver impregnation and the double immunostatin, its application to forensic neuropathology. Forensic Pathol (In Japanese) 2000;6:46-54.
24. Ikeda SI, Nobuo M, Yanagisawa M, Allsop D, Glenner GG. Early senile plaque in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry and electron microscopy. Hum Pathol 1990;21:1221-6.
25. Armstrong RA. Beta-amyloid plaques; Stages in life history or independent origin? Dement Geriatr Cong Disord 1998;9:227-38.
26. Szumanska G, Vorbrod AW, Mandybur TI, Wisniewski HM. Lectin histochemistry of plaques and tangles in Alzheimer's disease. Acta Neuropathol (Berl) 1987;73:1-11.
27. Mann DMA, Brown A, Prinja D, Davies CA, Landon M, Masters CL, Beyreuther K. An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Neuropathol Appl Neurobiol 1989;15:317-29.
28. Debray H, Decout D, Strecker G, Spik G, Montreul J. Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycoyl-proteins. Eur J Biochem 1981;117:41-55.
29. Guevara J, Espinosa B, Zenteno E, Vazguez L, Luna J, Perry G, Mena R. Altered glycosylation pattern of proteins in Alzheimer's disease. J Neuropathol Exp Neurol 1998;57:905-15.
30. Shioi J, Anderson JP, Ripellino JA, Robakis NK. Chondroichin sulfate proteoglycan from the Alzheimer's beta-amyloid precursor. J Biol Chem 1992;267:13819-22.
31. Snow AD, Nochlin D, Sekiguchi R, Carlson S. Identification and immuno-localization of a new class of proteoglycan (Keratan sulfate) to the neuritic plaques of Alzheimer's disease. Exp Neurol 1996;138:305-17.
32. Bruckner G, Hausen D, Hartig W, Drlicek M, Arendt T, Brauer K. Cortical areas abundant in extracellular matrix chondroitin sulfate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 1999;92:791-805.
33. Sparkman DR, Hill SJ, White III CL. Paired helical filaments are not the major binding sites for wheat germ and Dolichos biflorus agglutinins in the neurofibrillary tangles of Alzheimer's disease. Acta Neuropathol 1990;79:640-6.
34. Snow AD, Mar H, Nochlin D, Kress H, Wight TH. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J Histochem Cytochem 1992;40:105-13.
35. Wang JZ, Grundke-Iqubal I, Iqubal K. Glycosylation of microtubule associated protein tau: An abnormal posttranslational modification in Alzheimer's disease. Nat Med 1996;2:871-5.
36. Sato Y, Naito Y, Grundke-Iqubal I, Iqubal K, Endo T. Analysis of N-glycans of pathological tau: Possible occurrence of aberrant processing of tau in Alzheimer's disease. FEBS Lett 2001;496:152-60.
37. Liu F, Zaidi T, Iqbal K, Grundke-Iqubal I, Merkle RK, Gong CX. Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease. FEBS Lett 2002;512:101-6.
38. Hernandez F, Perez M, Lucas JJ, Avila J. Sulfo-glycosaminoglycan content affects PHT-tau solubility and allows the identification of different types of PHFs. Brain Res 2002;935:65-72.
39. Sun A, Nguyen XV, Bing G. Comparative analysis of an improved thioflavin-S stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J Histochem Cytochem 2002;50:463-72.
40. Harman D, Alzheimer's disease: Role of aging in pathogenesis. Ann NY Acad Sci 2002;959:384-95.
41. Nishimura A, Kurokawa K, Ikemoto K, Ohkubo I, Nishi K. Zebra bodies and membranous cytoplasmic bodies could be detected in the molecular layer of the dentate gyrus of the hippocampal formation of a patient with psychosis by means of immunoelectron microscopical technique. Acta Crim Japon (In Japanese) 2001;67:231-6.
42. Ferraro A, Damon LA. The histogenesis of amyloid bodies in the central nervous system. Arch Pathol 1931;12:229-44.
43. Ng'walali PM, Yonemitsu K, Kibayashi K, Tsunerai S. Neuropathological diagnosis of Alzheimer's disease in forensic autopsy of elderly persons with fatal accident. Legal Med 2002;4:223-31.
44. Cabanagh JB. Corpora-amylacea and family of polyglucosan disease. Brain Res Rev 1999;29:265-95.
45. Singhrao SK, Neal JW, Newman GR. Corpora amylacea could be an indicator of neurodegeneration. Neuropathol Appl Neurobiol 1993;19:269-76.
46. Palmucci L, Anzil AP, Luh S. Intra-astrocytic glycogen granules and corpora amylacea stain positively for polyglucosan: A cytochemical contribution of the fine structural polymorphism of particulate polysaccharides. Acta Neuropathol (Berl) 1982;57:99-102.
47. Schipper H, Cisse S. Mitochondrial constituents of corpora amylacea and auto-fluorescent astrocytic inclusion in senescent human brain. Glia 1995;14:55-64.
48. Fleming PD, Cordoza ME, Wood SG. Corpora amylacea increased in Alzheimer's disease. Neurology (Abstract) 1986;12:1314.
49. Behrmen S, Carrol JD, Janota I, Matthewa WB. Progressive supranuclear palsy. Clinico-pathological study of four cases. Brain 1969;92:663-78.
50. Robitaille Y, Carpenter S, Karpati G, DiMauro S. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocyte. Brain 1980;103:315-36.
51. Abe H, Yagishita S. Massive appearance of corpora amylacea in postnatal anoxic encephalopathy. Clin Neuropathol 1995;14:207-10.
52. Botez G, Rami A. Immunoreactivity for Bcl-2 and C-jun/AP1 in hippocampal corpora amylacea after ischaemia in humans. Neuropathol Appl Neurobiol 2000;27:474-80.
53. Buzzard EF, Greenfield JG. Pathology of the Nervous System. Constable, London: Constable; 1921.
54. Gati I, Leel-Ossy L. Heatshock protein 60 in corpora amylacea. Pathol Oncol Res 2001;7:140-4.
55. Nishi K, Ito N, Ishitani A, Nakajima M, Mizumoto J, Hirota T. Effects of different basic fuchsine analogs on staining properties of periodic acid schiff stain. Acta Crim Japon 1986;52:186-9.
56. Nishi K, Ito N, Ishitani A, Matsuda Y. Effects of different fuchsine analogs on aldehyde fuchsine staining of human cartilage. Jpn J Legal Med 1984;38:787-91.
57. Ito N, Nishi K, Kawahara S, Okamura Y, Hirota T, Rand S, Brinkmann B. Difference in the ability of blood group specific lectins and monoclonal antibodies to recognize the ABH antigens in human tissues. Histochem J 1990;22:604-14.
58. Nishimura A, Kurokawa K, Ikemoto K, Yamamoto Y, Rand S, Brinkmann B, Nishi K. Aberrant lectin-positive deposits in the hippocampal formation of schizophrenia. The 7th Indo Pacific Congress on Legal Medicine and Forensic Science (Abstract) 2001;160:1.
59. Eriksson P, Perfilieva E, Bjoerk-Eriksson T, Alborn A-M, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nat Med 1999;4:1313-7.
60. Seki T, Arai Y. Highly polysialated neural cell adhesion molecule (NCAM-H) is expressed by newly generated granule cells in the dentate gyrus of the adult rat. J Neurosci 1993;13:2351-8.
61. Dasgupta S, Horgan EL, Spicer SS. Stage-specific expression of fuconeolacto-(Lewis x) and ganglio-series neutral glycosphingolipids during brain development; Characterization of Lewis x and related glycosphingolipids in bovine, human and rat brain. Glycoconjugate J 1996;13:367-75.
62. Becker CG, Artola A, Gerardy-Schahn R, Becker T, Welz H, Schachner M. The polysialic acid modification of the neural cell adhesion molecule is involved in spatial learning and hippocampal long-term potentiation. J Neurosci Res 1996;45:143-52.
63. Perrimon N, Bernfield M. Specificities of heparan sulfate proteoglycans in developmental processes. Nature 2000;404:725-8.
64. Muramatsu T. Protein-bound carbohydrates on cell-surface as targets of recognition: An odyssey in understanding them. Glycoconjugate J 2000;17:577-95.
65. Wiederscain G, Ya Koul O, Aucoin JM, Smith FL, Mccluer RH. Alfa 1,3-fucosyltransferase, alfa-L-fucosidase, alfa-D-galactosidase, beta-D-galactosidase, and Le x glycoconjugates in developing rat brain. Glycoconjugate J 1998;15:379-88.
66. Bliss TVR, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973;232:331-56.
67. Parent A. Carpenter's Human Neuroanatomy, 9th ed. Baltimore MD: Williams and Wilkins; 1996.
68. Nakazawa K. An interdisciplinary approach to cognitive neuroscience. Cell Technol (In Japanese) 2002;21:982-5.
69. Cotter D, Wilson S, Roberts E, Kerwin R, Everall IP. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr Res 2000;41:313-23.
70. Shenton ME, Kikinis R, McCarely RWM, Metcalf D, Tieman J, Jolesz FA. Application of automated MRI volumetric measurement techniques to the ventricular system in schizophrenic and normal controls. Schizophr Res 1991;5:103-13.
71. Nishi K, Tanegashima A, Yamamoto Y, Ushiyama I, Yamazaki S, Nishikawa Y, Ohkubo I. Histochemical characteristic of perivascular space in the brain with an advanced edema. Legal Med 2003;:S280-S284.
72. Yamamoto Y, Ueki M, Nakagawa T, Ushiyama I, Nishimura A, Ito K, Nishi K. A fatal case due to overdose of gamma-hydroxybutylate. Jpn J Legal Med (Abstract, in Japanese) 2001;55:128.
73. Muller C, Viry S, Miehe M, Andriamampandry C, Aunis D, Maitre M. Evidence for a gamma-hydroxybutyrate (GHB) up-take by rat brain synaptic vesicles. J Neurochem 2002;80:899-904.
74. Brickman YG, Ford MG, Small DH, Bartlett PF, Nurcombe V. Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells. J Biol Chem 1995;270:24941-8.
75. Yamamoto Y, Li Y, Huang K, Ohkubo I, Nishi K. Isolation and characterization of an alanyl aminopeptidase from rat liver cytosol as a puromycin-sensitive enkepharin-degrading aminopeptidase. Biol Chem 1998;379:711-9.
76. Takahara S, Ushiyama I, Kozma Z, Yamamoto Y, Yamada M, Nishimura A, Ohkubo I, Nishi K. Immunohistochemical localization of alanyl amino-peptidase purified from human seminal plasma. Adv Legal Med 1997;3:615-7.
77. Rappolla SI. Blood-Brain Barrier in Physiology and Medicine. New York: Raven Press; 1976.
78. Kalatzo I. Pathophysiological aspects of brain edema. Acta Neuropathol (Berl) 1985;72:236-9.
79. Ringer L, Olsson Y. Studies on vascular permeability changes in experimental brain concussion. II. Duration of altered permeability. Acta Neuropathol (Berl) 1978;11:201-9.
80. Liu HM. Neovasculature and blood-brain barrier in ischemic brain infarct. Acta Neuropathol (Berl) 1988;75:422-6.
81. Nogami M, Takatsu A, Endo N, Ishiyama I. Immunohistochemical localization of heat shock protein 70 in the human medulla oblongata in forensic autopsies. Legal Med 1999;1:198-203.
82. Nogami M, Shiga I, Inuzuka N, Takatsu A. Age-associated decrease in 8-hydroxy-2′-deoxyguanosine(8-OHdG) immunoreactivity in the autopsied brain. Legal Med 2002;4:29-33.
83. Hausman R, Betz R. The course of MIB-1 expression by cerebral macrophages following human brain injury. Legal Med 2002;4:79-83.
84. Wisniewski HM, Kozlowski PB. Evidence for blood-brain barrier changes in senile dementia of Alzheimer type (SDAT). Ann NY Acad Sci 1982;396:119-29.
85. Ueno M, Tomimoto H, Akiguchi I, Wakita H, Sakamoto H. Blood-brain barrier in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 2002;22:97-104.
86. Oehmichen M, Genci M. Postmortal diffusion of plasma albumin in rat brain. Z Rechtsmed 1980;84:113-23.
87. Leestma JE, Magee DJ. Forensic aspect of general neuropathology. In: Leestma JE, editor. Forensic Neuropathology. New York: Raven Press; 1988. p. 24-156.
88. Schwedenberg TH. Leukoencephalopathy following carbon monoxide asphyxia. J Neuropathol Exp Neurol 1959;18:597-608.
89. Hirano A, Zimmerman HM. Some new pathological findings in the central myelinated axon. J Neuropathol Exp Neurol 1971;30:325-36.
90. Brun A, Englund E. A white matter disorder in dementias of the Alzheimer's type: A pathological study. Ann Neurol 1986;19:253-62.
91. Award IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I: Correlation with age and cerebrovascular risk factor. Stroke 1986;17:1084-9.
92. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report; A review. Stroke 1995;26:382-7.
93. Pantoni L, Garcia JH, Gutierrez A. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996;27:1641-7.
94. Huang K, Wu L, Luo Y. Binswanger's disease: Progressive subcortical encephalopathy or multi-infarct dementia? Can J Neurol Sci 1985;12:88-94.
95. Pantoni L, Garcia JH. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann NY Acad Sci 1997;826:92-102.
96. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002;13(2):7-10.
97. Tsokos M. Immunohistochemical detection of sepsis-induced lung injury in human autopsy material. Legal Med 2003;5:72-86.